X
Wedesday, May 28, 2025
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Detecting Traces of β-Lactam Antibiotics Using UHPLC-MS-MS

Content Team by Content Team
24th November 2022
in News, Research & Development

The identification and detection of the β-lactams cephapirin and ceftiofur in cleaning solutions of the production reactors have been validated using ultra-performance liquid chromatography with a triple quadrupole mass spectrometry, or UHPLC-MS/MS, according to a paper published in the journal Molecules.

It is important and regulated to conduct trace detection of β-lactam antibiotics in cleaning rinse solutions and production aids in pharmaceutical plants. Patients who utilise medications have a high risk of experiencing cross contamination with β-lactams because even minute levels of them might result in potentially fatal responses. Additionally, during the cleaning procedure, pollutants like cephapirin and ceftiofur that are prevalent in production reactors may transfer into the cleaning solution.

According to the research, a number of complex and time-consuming analytical methods have historically been used to determine β-lactams, comprising radioimmunoassay, microbial inhibition, enzyme-linked immunosorbent assay, bioluminescent immunoassay, and biosensors. Hazardous antibiotic pollutants have been identified and removed using molecularly imprinted polymer nanoparticles, as well as other metal and metal oxide nanoparticles. However, according to the article, they lack specificity and are only appropriate when qualitative data is needed.

Another option is to use spectroscopic techniques, but as β-lactam antibiotics lack chromophores, the technique requires a sufficient derivatization to provide colour. The study continued that several spectroscopic approaches suffer from a long analysis time and were created using traditional high-performance liquid chromatography (HPLC) with UV detection. However, LC-MS/MS approaches have not been particularly mentioned for β-lactam derivatives of cephapirin and ceftiofur at trace quantities in medicinal products or on industrial surfaces.

The study said that it is necessary to design an easy, quick, and precise multi-residue analytical approach that involves ultra-high efficiency liquid chromatographic methodology.

Rapid analysis with UHPLC-MS/MS

At an oven temperature of roughly 40 °C, analysis was conducted using a C18 column that was 100mm long, 4.6mm in diameter, and had a 3.5 m particle size. 0.15% formic acid in water and mobile phases A and B of acetonitrile made up the mobile phase. A flow rate of 0.6 mL/min was used.

According to Chittireddy et al research, the lowest limit of discovery for quantitative accuracy and precision was 0.15 parts per billion (ppb), while the lowest limit of quantification was 0.4 ppb. It was fit-for-purpose for detecting and quantifying trace levels of β-lactam contamination, tracking cross – infection in facility surface cleaning, and calculating the adequate standard of limits for regulatory purposes to use a quick and accurate procedure.

Previous Post

Leprosy-Causing Bacteria May Be Able To Regenerate Livers

Next Post

EMA Forms Quality Control Group To Boost Drug Innovation

Related Posts

Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Next Post

EMA Forms Quality Control Group To Boost Drug Innovation

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Notifications